ASCO guideline update (33 RCTs, 16 systematic reviews) on colony-stimulating factors in adults with cancer: prophylaxis is warranted when chemotherapy febrile neutropenia risk is about 20% or higher, and may be warranted below 20% in high-risk patients.
Guideline
Gyawali et al. WBC Growth Factors: ASCO Guideline Update